Interestingly, in a study where samples from primary prostate cancer and benign prostatic hyperplasia were compared, three AR isoforms were dysregulated, and their opposing expression profiles correlated with disease aggressiveness [64]. This evidence concerns the gene AR and prostate carcinoma.